Literature DB >> 17522281

Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States.

Jon M Counts1, J Rex Astles, Fred C Tenover, Janet Hindler.   

Abstract

Laboratory practice in the preanalytical phase of antimicrobial susceptibility testing (AST) was evaluated in 102 hospital, reference, physician office-clinic, and public health laboratories in Washington state. Surveys were sent to evaluate (i) use of NCCLS/CLSI (formerly NCCLS) AST performance standards, (ii) technical competence in AST case studies, challenging knowledge of contemporary testing issues, and (iii) choice of antimicrobial agents to test for Streptococcus pneumoniae. Numerous deficiencies were identified in the survey: (i) initially only 40% of the laboratories surveyed used current NCCLS/CLSI AST performance standards, (ii) the rate of accurate responses for three different case studies ranged from 29% to 69%, and (iii) variation was noted in the choice of antimicrobials tested against invasive isolates of S. pneumoniae. These deficiencies could affect therapy and detection of antimicrobial resistance. Several educational programs were implemented to improve AST policies and practices, and a follow-up survey indicated that four intervention strategies were most effective: (i) regional technical workshops, (ii) National Laboratory Training Network teleconferences, (iii) use of the Centers for Disease Control and Prevention (CDC) CD-ROM on AST, and (iv) the CDC Multilevel Antimicrobial Susceptibility Testing Resource website. The interventions could be implemented more widely in the United States to improve AST knowledge and practices.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522281      PMCID: PMC1933004          DOI: 10.1128/JCM.00184-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.

Authors:  C D Steward; D Wallace; S K Hubert; R Lawton; S K Fridkin; R P Gaynes; J E McGowan; F C Tenover
Journal:  Diagn Microbiol Infect Dis       Date:  2000-09       Impact factor: 2.803

3.  Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: a report from the College of American Pathologists Microbiology Proficiency Survey Program.

Authors:  G V Doern; A B Brueggemann; M A Pfaller; R N Jones
Journal:  Arch Pathol Lab Med       Date:  1999-04       Impact factor: 5.534

4.  Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards.

Authors:  Kurt B Stevenson; Matthew Samore; James Barbera; James W Moore; Elizabeth Hannah; Peter Houck; Fred C Tenover; Julie L Gerberding
Journal:  Diagn Microbiol Infect Dis       Date:  2003-09       Impact factor: 2.803

Review 5.  Confronting bacterial resistance in healthcare settings: a crucial role for microbiologists.

Authors:  John E McGowan; Fred C Tenover
Journal:  Nat Rev Microbiol       Date:  2004-03       Impact factor: 60.633

6.  Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance.

Authors:  Margaret L Heginbothom; J T Magee; Joanna L Bell; F D J Dunstan; A J Howard; Sharon L Hillier; S R Palmer; B W Mason
Journal:  J Antimicrob Chemother       Date:  2004-04-21       Impact factor: 5.790

7.  Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.

Authors:  J Barenfanger; C Drake; G Kacich
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

8.  Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.

Authors:  F C Tenover; M J Mohammed; J Stelling; T O'Brien; R Williams
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

9.  Sentinel surveillance as an alternative approach for monitoring antibiotic-resistant invasive pneumococcal disease in Washington State.

Authors:  D B Jernigan; L Kargacin; A Poole; J Kobayashi
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 10.  Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership.

Authors:  D A Goldmann; R A Weinstein; R P Wenzel; O C Tablan; R J Duma; R P Gaynes; J Schlosser; W J Martone
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

View more
  4 in total

1.  Origins and development of the National Laboratory System for public health testing.

Authors:  J Rex Astles; Vanessa A White; Laurina O Williams
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

2.  Systematic review of antibiograms: A National Laboratory System approach for improving antimicrobial susceptibility testing practices in Michigan.

Authors:  Martha S Boehme; Patricia A Somsel; Frances Pouch Downes
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

3.  Surveillance of Gram-negative bacteria: impact of variation in current European laboratory reporting practice on apparent multidrug resistance prevalence in paediatric bloodstream isolates.

Authors:  J A Bielicki; D A Cromwell; A Johnson; T Planche; M Sharland
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-26       Impact factor: 3.267

4.  Postoperative nosocomial infections among children with congenital heart disease.

Authors:  Jian Zhang; Yan Yuan; Peiling Li; Tuanjie Wang; Jun Gao; Jinhua Yao; Shujun Li
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.